Longeveron Inc. (NASDAQ: LGVN)
$3.54
-0.4150 ( -10.50% ) 2.3M
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Market Data
Open
$3.54
Previous close
$3.95
Volume
2.3M
Market cap
$33.80M
Day range
$3.37 - $4.03
52 week range
$0.77 - $37.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 10, 2024 |
8-k | 8K-related | 13 | Jul 03, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
8-k | 8K-related | 18 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 11, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
def | Proxies and info statements | 4 | May 20, 2024 |
ars | Annual reports | 1 | May 20, 2024 |
10-q | Quarterly Reports | 72 | May 14, 2024 |
4 | Insider transactions | 1 | May 14, 2024 |